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The treatment of Askin tumor: Results of two cases 
Iwao Takanami, MD,a and Tetsuo Imamura, MD,b Tokyo, Japan
Primitive neuroectodermal tumor of the thoracopulmonaryregion is a rare tumor found in children and young adultsand has been referred to as Askin tumor.1 Askin tumorstypically involve the periosteum, soft tissues, and extra-
pulmonary tissue of the thoracic wall, and the prognosis is very
poor.2 This article describes long-
term survival in 2 patients whom we
treated for Askin tumor.
Patients and Methods
Two patients, 1 woman and 1 man, 32
and 16 years of age, with Askin tumor were treated in our insti-
tute between 1990 and 2001 (Table 1). The clinical and mor-
phologic findings with immunohistochemical staining3 involv-
ing HBA-71 support the diagnosis of Askin tumor in these
patients. At the time of the initial diagnosis, neither of the
patients had metastases. We performed chest wall resections
involving the ribs in both patients, and both subsequently
received chemotherapy. Their chemotherapeutic regimens con-
sisted of cyclophosphamide, doxorubicin (Adriamycin), vin-
cristine, and dactinomycin (actinomycin D). 
Results
Patient 1 remains well with no evidence of disease at 7 years.
Patient 2 subsequently required 6 further excisions of local recur-
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rences of Askin tumor with postoperative chemotherapy and radio-
therapy over a 7-year period. He finally died of the disease 7.5
years after the initial diagnosis (Table 2).
Discussion 
Askin tumor is not easy to diagnose because its appearance under
a light microscope is similar to Ewing sarcoma, rhabdomyosarco-
ma, and neuroblastoma.4 In our patients, most of the clinical and
morphologic findings supported an Askin tumor diagnosis. Askin
tumor is more commonly seen in girls in older childhood or ado-
lescence,1 but one of our patients was a 32-year-old woman.
Askin tumor may present as a chest wall mass with thoracopul-
monary symptoms such as chest pain, cough, or dyspnea. In our
patient 1 a posterior pleural mass was discovered during routine
radiographic screening without symptoms, whereas patient 2 had
an expanding mass in the chest wall accompanied by pain.
Removal was possible in both patients. In patient 1, complete
removal of the tumor with chest wall resection involving 4 ribs,
followed by chemotherapy, was possible. In patient 2, complete
removal may not have been achieved during the first operation.
Askin tumor has a predilection to reappear in approximately the
same area as the primary neoplasm.1 Metastases to the pleura, rib,
pericardium, diaphragm, and vertebra/spinal cord were easily
detected by computed tomographic scanning and magnetic reso-
nance imaging in patient 2. Even though we performed relatively
wide excisions of the local Askin tumor recurrences followed by
chemotherapy and radiotherapy, tumors continued to appear at
sites adjacent to the excised tumor, and Askin tumor recurred
locally 6 times in 7 years. 
The prognosis in Askin tumor is very poor despite the combina-
tion of chemotherapy, radiotherapy, and surgical removal, with a 2-
year survival of 38% and a 6-year survival of only 14%.2 Very few
cases have been reported in which the patient is still alive. Our
patients received aggressive combined therapy, and the outcome was
more favorable than that reported in the literature. From our prelim-
inary data, we suggest that Askin tumor should be treated with com-
plete surgical excision followed by an aggressive chemotherapy reg-
imen. For local recurrences, postoperative chemotherapy and
radiotherapy after complete excision help to prolong survival. A
multimodal therapy consisting of surgical resection, appropriate
chemotherapy, and radiotherapy seems to be of some benefit in treat-
ing Askin tumor, and even in treating recurrences.
References
1. Askin FB, Rosai J, Sibley RK, Dehner LP, McAlister WH. Malignant
small cell tumor of the thoracopulmonary region in childhood: a dis-
tinctive clinicopathologic entity of uncertain histogenesis. Cancer.
1979;43:2438-51.
2. Contesso G, Llombert-Bosch A, Terrier P, Peydro-Olaya A, Henry-
Amar M, Oberlin J, et al. Does malignant small round cell tumor of
the thoracopulmonary region (Askin tumor) constitute a clinicopatho-
logic entity? An analysis of 30 cases with immunohistochemical and
electron-microscopic support treated at the Institute Gustave Roussy.
Cancer. 1992;69:1012-9.
3. Fellinger EJ, Garin-Chesa P, Su SL, DeAngelis P, Lane JM, Retting
WJ. Biochemical and genetic characterization of HBA71 Ewing’s sar-
coma cell surface antigen. Cancer Res. 1991;51:336-40.
4. Triche TJ, Askin FB, Kissane JM. Neuroblastoma, Ewing’s sarcoma
and the differential diagnosis of small-, round-, blue-cell tumors.
Philadelphia: WB Saunders; 1986. p. 145-95.
TABLE 1. Patients with Askin tumor: Primary site and treat-
ment 
Case (age Chief Treatment for
[y], sex) symptom Primary site primary tumor
1 (32, F) Abnormal shadow Right posterior Chest wall resection
on chest film pleura with 4 ribs,
chemotherapy*
2 (16, M) Expanding mass Left posterior Chest wall resection
chest wall with 2 ribs,
chemotherapy*
*Cyclophosphamide, doxorubicin (Adriamycin), vincristine, and dactino-
mycin (actinomycin D).
TABLE 2. Results with Askin tumor
Case Recurrence and treatment Results
1 No evidence of disease Alive at 7 y
2 Six excisions of local recurrences, Dead at 7.5 y
chemotherapy,* and radiotherapy
*Cyclophosphamide, doxorubicin (Adriamycin), vincristine, ifosfamide,
and pirarubicin.
